author-photo

Ashleigh Wilkinson

Garvan Institute of Medical Research

3

Papers

3

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Epigenetic therapy suppresses endocrine-resistant breast tumour growth by re-wiring ER-mediated 3D chromatin interactions

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (2)
Cyclin E1 protein is stabilized in BRCA1 mutated breast cancers leading to synergy between CDK2 and PARP inhibitors

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)